Presidents' Council
Dr. Danzig brings more than 20 years of infectious disease R&D experience, including advancing novel vaccines and diagnostics from research stage through clinical development. Most recently, she has worked with Pandefense Advisory helping various institutions, non-profits, companies, and governments around the world on COVID-19 responses and protocols. In July 2021, Dr. Danzig was awarded Peru’s Order of “Merit for Distinguished Services” at the rank of Grand Official for her outstanding contributions that enabled effective vaccine procurement.
Dr. Danzig previously served as EVP and Chief Medical Officer at infectious disease and travel vaccine developer, PaxVax. Prior to PaxVax, she held senior global roles at Novartis Vaccines and Diagnostics, Inc., supporting both the blood screening diagnostic and vaccines business units. Dr. Danzig began her industry career at Chiron Corporation, leading the clinical meningococcal franchise team, before the Company was acquired by Novartis International AG.
Before joining the industry, she served as an Epidemic Intelligence Service Officer for the CDC (Centers for Disease Control and Prevention) in the Nosocomial Infections Surveillance Activity Branch, Hospital Infections Program, and completed an Infectious Diseases fellowship at UCSF-Mt. Zion. A published author in the Wall Street Journal and Foreign Affairs, Dr. Danzig earned her M.D. from Oregon Health and Science University School of Medicine and a B.S. in Biology from Reed College.